netFormulary NHS
Nottinghamshire Area Prescribing Committee
Joint Formulary
 Search
 Formulary Chapter 7: Obstetrics, Gynaecology, and urinary-tract disorders - Full Chapter
07.04.01  Expand sub section  Drugs for urinary retention
07.04.01  Expand sub section  Alpha-blockers
Alfuzosin (Xatral®)
View adult BNF View SPC online View childrens BNF
Formulary
Green
Tablet
  • If needed normal release tablets can be dispersed in water. Do not crush MR tablets. More Info
     
  •    
    Doxazosin
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green

    Tablet

    • See Section 2.5.4 for use as antihypertensive.
    • If needed tablets can be crushed and dispersed in water. Do not crush MR formulations. Click here for more information.
     
    Link  SPS Q&A: Switching from doxazosin XL tablets to doxazosin standard release tablets
    Link  UKMI Q&A: How should conversion between doxazosin formulations be carried out?
    Link  UKMI Q&A: What is the evidence comparing doxazosin XL with standard doxazosin?
       
    Tamsulosin
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Capsules MR
  • If needed capsules can be opened and contents dispersed in water. However the contents clump together when mixed with water and will block feeding tubes. The granules are modified release, so they must not be crushed or chewed. More Info
  • Always prescribe as CAPSULES (the tablets cost twice as much - £10pm v £5).  
  •    
    07.04.01  Expand sub section  Parasympathomimetics
     ....
     Non Formulary Items
    Dutasteride and Tamsulosin  (Combodart®)

    View adult BNF View SPC online View childrens BNF
    Non Formulary
    Grey
    Capsule
  • Not for first line use.
  • August 2015 more expensive than constituent components and significantly more expensive than finasteride and doxazocin in combination.
  • See dutasteride entry regarding possibility of switching patients if clinically appropriate.
  •  
    Indoramin  (Doralese®)

    View adult BNF View SPC online View childrens BNF
    Non Formulary
    Grey
     
    Prazosin

    View adult BNF View SPC online View childrens BNF
    Non Formulary
    Grey
     
    Terazosin

    View adult BNF View SPC online View childrens BNF
    Non Formulary
    Grey
     
      
    Key
    note Notes
    Section Title Section Title (top level)
    Section Title Section Title (sub level)
    First Choice Item First Choice item
    Non Formulary Item Non Formulary section
    Restricted Drug
    Restricted Drug
    Unlicensed Drug
    Unlicensed
    Track Changes
    Display tracking information
    click to search medicines.org.uk
    Link to adult BNF
    click to search medicines.org.uk
    Link to children's BNF
    click to search medicines.org.uk
    Link to SPCs
    SMC
    Scottish Medicines Consortium
    Cytotoxic Drug
    Cytotoxic Drug
    CD
    Controlled Drug
    High Cost Medicine
    High Cost Medicine
    Cancer Drugs Fund
    Cancer Drugs Fund
    NHSE
    NHS England
    Homecare
    Homecare
    CCG
    CCG

    Traffic Light Status Information

    Status Description

    Grey

    Grey / Non-Formulary: Medicines, which the Nottinghamshire APC has actively reviewed and does not recommend for use at present due to limited clinical and/or cost effective data.
    Grey / Non-Formulary (undergoing assessment): Work is ongoing and will be reviewed at a future APC meeting.
    Grey / Non-Formulary (no formal assessment): APC has not formally reviewed this medicine or indication because it had never been requested for formulary inclusion. Often used for drugs new to market.
      

    Red

    Medicines which should normally be prescribed by specialists only. eg hospital only.
    For patients already receiving prescriptions in primary care - continue. No new patients to receive prescriptions in primary care.
      

    Amber 1

    Medicines that should be initiated by a specialist and prescribed by primary care prescribers only under a shared care protocol, once the patient has been stabilised.
    Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s) (DTC) and approved by the Nottinghamshire APC.
      

    Amber 2

    Medicines suitable to be prescribed in primary care / general practice after specialist* recommendation or initiation.
    A supporting prescribing guideline may be requested which must have been agreed by the relevant secondary care trust DTCs and approved by the Nottinghamshire APC.
    *Specialist is defined by the APC as a clinician who has undertaken an appropriate formal qualification or recognised training programme within the described area of practice
      

    Amber 3

    Primary care/ non specialist may initiate as per APC guideline.
    The supporting prescribing guideline must have been agreed by the relevant secondary care trust D&TC(s) and approved by the Nottinghamshire APC.
      

    Green

    Medicines suitable for routine use within primary care.
    Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing.   

    OTC

      

    netFormulary